Below are the most recent publications written about "Living Donors" by people in Profiles.
-
Cheah YL, Yang HY, Simon CJ, Akoad ME, Connor AA, Daskalaki D, Han DH, Brombosz EW, Kim JK, Tellier MA, Ghobrial RM, Gaber AO, Choi GH. The learning curve for robotic living donor right hepatectomy: Analysis of outcomes in 2 specialized centers. Liver Transpl. 2025 Feb 01; 31(2):190-200.
-
Kanneganti M, Byhoff E, Serper M, Olthoff KM, Bittermann T. Neighborhood-level social determinants of health measures independently predict receipt of living donor liver transplantation in the United States. Liver Transpl. 2024 Jun 01; 30(6):618-627.
-
Long JJ, Motter JD, Jackson KR, Chen J, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen JR, Bozorgzadeh A, Gaber AO, Heher EC, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Massie AB, McAdams-DeMarco MA, Segev DL, Garonzik-Wang JM. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients. Am J Transplant. 2023 12; 23(12):1980-1989.
-
Kling CE, Biggins SW, Bambha KM, Feld LD, Perkins JH, Reyes JD, Perkins JD. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies. JAMA Surg. 2023 06 01; 158(6):610-616.
-
Bellini MI, Nozdrin M, Naesens M, Martins PN. Eliminating Race From eGFR Calculations: Impact on Living Donor Programs. Transpl Int. 2022; 35:10787.
-
Sakai T, Ko JS, Crouch CE, Kumar S, Choi GS, Hackl F, Han DH, Kaufman M, Kim SH, Luzzi C, McCluskey S, Shin WJ, Sirianni J, Song KW, Sullivan C, Hendrickse A. Perioperative management of living donor liver transplantation: Part 2 - Donors. Clin Transplant. 2022 06; 36(6):e14690.
-
Martins PN, Clavien PA. Comment on "Making Every Liver Count Increased Transplant Yield of Donor Livers Through Normothermic Machine Perfusion". Ann Surg. 2021 12 01; 274(6):e839-e841.
-
Ridha M, Jones DG, Lerner DP, Vytopil M, Voetsch B, Burns JD, Ramineni A, Raibagkar P. The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation. Virol J. 2021 08 06; 18(1):162.
-
Motter JD, Jackson KR, Long JJ, Waldram MM, Orandi BJ, Montgomery RA, Stegall MD, Jordan SC, Benedetti E, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Verbesey JE, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Wellen JR, Bozorgzadeh A, Gaber AO, Heher EC, Weng FL, Djamali A, Helderman JH, Concepcion BP, Brayman KL, Oberholzer J, Kozlowski T, Covarrubias K, Massie AB, Segev DL, Garonzik-Wang JM. Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation. Am J Transplant. 2021 04; 21(4):1612-1621.
-
Ziogas IA, Martins PN, Alexopoulos SP, Matsuoka LK, Rauf MA, Geevarghese SK, Gorden LD, Karp SJ, Perkins JD, Montenovo MI. Effect of Donor Transaminase Levels on Graft Survival Following Liver Transplant: An Analysis of the Organ Procurement and Transplantation Network Database. Exp Clin Transplant. 2021 03; 19(3):250-258.